| عنوان البحث | ملخص البحث |
| العلاج بعقارى الجمزار والأوكسالوبلاتين كخط أول فى مرضى سرطان الكبد المتقدم | |
| The diagnostic and prognostic value of CD38 and CD49d
expressions in chronic lymphocytic leukemia | |
| Potential value of circulatory microRNA122 gene expression
as a prognostic and metastatic prediction marker for breast cancer | |
| The clinical impact of miRNA34a and P53 gene expression in colon cancer | |
| Relation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients | |
| Association of Serum Vitamin D Level and Vitamin D Receptor Polymorphism (Apa 1) and Breast Cancer | |
| Validity and clinical impact of glucose transporter 1
expression in colorectal cancer | |
| Clinical Outcome of Exocrine Pancreatic Adenocarcinoma: A Single Center
Experience | |
| Clinical Value of C-reactive Protein and Erythrocyte Sedimentation Rate in
Advanced Bladder Cancer | |
| Clinical Value of Serum Neopterin in Breast Cancer | |
| Study of distribution of bone metastases in metastatic breast cancer patients
compared to other major cancers | |
| Effect of Body Mass Index on Survival in Patients with Epithelial Ovarian Cancer | |
| Impact of breast surgery on response and survival in
metastatic breast cancer patients | |
| Incidence of MRSA infection in pneumonia
in cancer patients with phenotyping & genotyping
study | |
| Clinical Features and Outcomes of Carcinoma of Unknown Primary Site: A
Single Center Experience | |
| The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients | |
| Factor V Leiden and prothrombin G20210A gene mutations in cancer patients with thromboembolic events | |
| Role of Aspergillus Galactomannan Antigen Test for
the Screening of Invasive Aspergillosis in Patients
with Hematological Malignancies | |
| Clinico-Epidemiology Study of Colorectal Cancer in Menofia University Oncology Department | |
| Plasma fibrinogen level as possible prognostic
biomarker in diffuse large B-cell lymphoma | |
| Evaluation Of Receptor For Advanced Glycation End Product /High-Mobility Group Box 1 (RAGE/HMGB1) Expression Status And its Prognostic Value In Breast Cancer | |
| Potential role of MicroRNA 200c gene expression in assessment of colorectal
cancer | |
